Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.5K Sell
214
-212
-50% -$24.8K 0.01% 335
2026
Q1
$51.2K Sell
426
-559
-57% -$64.5K 0.02% 236
2025
Q4
$104K Sell
985
-1,806
-65% -$170K 0.03% 173
2025
Q3
$234K Sell
2,791
-676
-19% -$55.7K 0.09% 120
2025
Q2
$274K Sell
3,467
-495
-12% -$39.3K 0.11% 112
2025
Q1
$356K Buy
3,962
+522
+15% +$48.7K 0.18% 81
2024
Q4
$342K Buy
3,440
+2,517
+273% +$259K 0.13% 77
2024
Q3
$105K Buy
923
+664
+256% +$78.9K 0.05% 127
2024
Q2
$32.1K Buy
259
+44
+20% +$5.67K 0.01% 213
2024
Q1
$28.4K Sell
215
-59
-22% -$7.27K 0.01% 235
2023
Q4
$29.9K Buy
+274
New +$28.4K 0.02% 198

Other funds holding MRK

Rakuten Securities's MRK Position: Q2 2026 in Review

Rakuten Securities reduced its Merck (MRK) stake by 50% in Q2 2026, selling an estimated $24.8K and leaving 214 shares worth $27.5K. The position accounts for 0.01% of the portfolio, ranked #335.

Rakuten Securities first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $356K in Q1 2025. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Rakuten Securities held 214 shares of Merck worth $27.5K as of Q2 2026.
  • Rakuten Securities sold 212 Merck shares in Q2 2026, an estimated $24.8K.
  • Merck made up 0.01% of Rakuten Securities's portfolio in Q2 2026, its #335 holding.
  • Rakuten Securities first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • Rakuten Securities's Merck position peaked at $356K in Q1 2025.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.